Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.
about
Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complementComplete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1rFluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognitionThe Serine Protease Domain of MASP-3: Enzymatic Properties and Crystal Structure in Complex with EcotinBaculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate.Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sitesMapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.Analogous interactions in initiating complexes of the classical and lectin pathways of complementRecombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseasesThe N-terminal CUB-epidermal growth factor module pair of human complement protease C1r binds Ca2+ with high affinity and mediates Ca2+-dependent interaction with C1s.Identification of a cryptic protein kinase CK2 phosphorylation site in human complement protease Clr, and its use to probe intramolecular interaction.Identification of erythro-beta-hydroxyasparagine in the EGF-like domain of human C1r.Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sitesStructural and Functional Characterization of a Single-Chain Form of the Recognition Domain of Complement Protein C1q.Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement.Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complementNeutron scattering studies of the isolated C1r2C1s2 subunit of first component of human complement in solution.Calcium binding properties of the C1 subcomponents C1q, C1r and C1s.Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.Complement protein C1q forms a complex with cytotoxic prion protein oligomersAutoactivation of human complement subcomponent C1r involves structural changes reflected in modifications of intrinsic fluorescence, circular dichroism and reactivity with monoclonal antibodies.Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.Interaction between complement subcomponent C1q and bacterial lipopolysaccharides.Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.Primary structure of the A chain of human complement-classical-pathway enzyme C1r. N-terminal sequences and alignment of autolytic fragments and CNBr-cleavage peptides.Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.The quaternary structure in solution of human complement subcomponent C1r2C1s2.C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937
P2860
Q24291623-91C34D70-EA70-4C62-8352-70454AE6AEE4Q24304038-6175982E-416D-4264-9ACF-2269E6BAA13AQ24529323-4E62C2F0-515E-4362-82DE-5726A4BCC963Q24531136-FB5A24C7-EE40-4614-9E28-AA30D22B957EQ24675546-6C8B09EB-0757-49E1-AE1D-F1563DFDE252Q24681784-C0967859-378F-4BF8-9329-11D0706D4B47Q27649785-64AC411D-6D8C-4C51-8A37-1AB9E23CB327Q27679119-CCB00747-E5E1-4000-9429-E1D18911E35AQ32155073-0EAFFA53-01B1-4639-8FDC-90E036D05A46Q33518329-94F5E102-5269-46AF-AEC0-C0BAB50D24E9Q33622210-9E843A61-9C6A-4F31-8CEA-9856289E7EF3Q33666670-B610B824-29F3-48B5-81F2-09BA6D2B152EQ33667582-39811F5F-455E-4380-937A-08CF2214CBFDQ33856219-C970C95F-7F55-44F3-91FF-A75995BF4818Q34380375-4F0E2181-A8D4-460A-AC04-2D962F0726BBQ34551393-EB3CFD1E-95E1-4608-8B88-B16FC00C80ECQ34708256-03747930-619C-4A27-83D3-233DD31AF6DAQ36640161-07F26A01-D2B2-4234-BFF1-CD6875FBD2ADQ37339284-9659CCA9-E5D3-41C2-B8EC-AC454608D1E5Q37545913-5414FCB1-0C84-4B20-AAB1-1C7D50D7F74DQ37615332-D0D09BE5-A57A-47F1-A501-4D9F509D4386Q38524562-AC419687-64DB-48E7-9219-BB77C9A394B0Q40378825-94549FD9-F3DD-4942-9187-70F2ABC1D375Q41048016-78BB9DDD-22FB-4742-A3F1-C90CFF294722Q41558464-18274F94-8A61-4750-A26C-3E43BA450EFBQ41809696-7C53F62D-2006-47DC-973C-AC45FC28D2A9Q41841696-7E9E7519-220B-4A75-9C2F-C34A7A0CB407Q41843990-3838F726-B543-473C-BDEE-089873A5708DQ41876239-59A84D3E-9442-437E-99FC-9E1CB807E85EQ41896725-8A1AE495-31E6-4294-B006-7A651420D58CQ41941786-16510029-FC0B-4DD2-A105-0ADA88AC671CQ41964619-C069A51A-1B17-4841-8628-FB48C9579B5BQ42142949-C2E4F812-71D7-49E1-ADB0-DF08938C1674Q42154683-14CC0728-758A-487F-9DF8-9E7EEAE0BDF0Q42158032-6BA714C3-B3C5-4BBE-BDE8-CD6BD4F628ABQ42168096-B6C51E74-F522-4544-ABC7-03CDE40E9ED3Q42803536-76486F52-8BD4-4CF5-A92C-CA1F5E0DA223Q42803888-1ADBCFF5-CBFF-4E08-9299-FD7AD80D6F24Q42821295-D55FBD43-F7A7-4B7F-9CCA-0C4533F2CDD2Q42836599-AF15E83C-9C26-42DA-9F70-B2A174C4E159
P2860
Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Differential elution of Clq, C ...... ification of Cl subcomponents.
@en
Differential elution of Clq, C ...... ification of Cl subcomponents.
@nl
type
label
Differential elution of Clq, C ...... ification of Cl subcomponents.
@en
Differential elution of Clq, C ...... ification of Cl subcomponents.
@nl
prefLabel
Differential elution of Clq, C ...... ification of Cl subcomponents.
@en
Differential elution of Clq, C ...... ification of Cl subcomponents.
@nl
P2093
P1433
P1476
Differential elution of Clq, C ...... ification of Cl subcomponents.
@en
P2093
P304
P356
10.1016/0161-5890(79)90069-5
P577
1979-07-01T00:00:00Z